Antibody Levels Of Health Personnel Post-Booster Vaccination Phase-III

Nur Fajri* -  Department of Midwifery, Graduate School, Hasanuddin University, Indonesia, Indonesia
Muh. Nasrum Massi -  1Department of Midwifery, Graduate School, Hasanuddin University, Indonesia, Indonesia
DOI : 10.33024/jkm.v8i4.7668
ABSTRACK

Background: Health workers are one of the groups most at risk of being infected with Covid-19 due to their intense interactions with patients. Therefore, it is necessary to make efforts to increase the endurance of the pandemic by administering vaccines.

Purpose: This study aims to determine the effectiveness of giving phase III booster vaccinations for health workers against increasing Covid-19 antibody titers.

Methode: This study belongs to the type of descriptive quantitative research, the sampling technique is carried out using the slovin formula.

Results: The results showed that constantly (100%), giving booster vaccinations to health workers can increase the effectiveness of the Covid-19 vaccine that has previously been given and is able to strengthen the antibody that has been awakened.  

Conclusion: The administration of the phase III booster vaccine can increase the titer of the Covid-19 antibody so that the risk of transmission of the corona virus can be suppressed.

Suggestion: Other puskesmas can carry out phase-III booster vaccinations for health workers as a whole

  1. Amir, H. (2021). Tenaga Kesehatan di Gowa Mulai Jalani Vaksinasi Booster. sindonews.com, 1–1.
  2. Arami, M. W., Purnamasari, N., & Rahayu, S. (2022). Jurnal Mahasiswa BK An-Nur : Berbeda , Bermakna , Mulia Volume 8 Nomor 2 Tahun 2022 Tersedia Online : https://ojs.uniska-bjm.ac.id/index.php/AN-NUR ANALISA YANG MEMPENGARUHI KEPUTUSAN TENAGA KESEHATAN MELAKUKAN VAKSINASI COVID-19 DOSIS LANJUTAN ( BOOSTER ) Dipublikasikan Oleh : UPT Publikasi dan Pengelolaan Jurnal Universitas Islam Kalimantan Muhammad Arsyad Al-Banjari Banjarmasin Jurnal Mahasiswa BK An-Nur : Berbeda , Bermakna , Mulia Volume 8 Nomor 2 Tahun 2022 Tersedia Online : https://ojs.uniska-bjm.ac.id/index.php/AN-NUR Dipublikasikan Oleh : UPT Publikasi dan Pengelolaan Jurnal Universitas Islam Kalimantan Muhammad Arsyad Al-Banjari Banjarmasin. 8, 51–54.
  3. Balaputra STIKes Bhakti Al-Qodiri Program Studi, I. S. (2022). Mewujudkan Masyarakat Sehat dan Produktif dengan Vaksinasi Covid-19 Dosis Lanjutan (Booster). Jurnal Pengabdian Masyarakat Al-Qodiri (JPMA), 1(1), 9–14.
  4. Banjarnahor, S., Studi, P., & Keperawatan, I. (2021). Analisa Penularan Covid-19 Pada Perawat Di Rumah Sakit. Jurnal Perawat Indonesia, 5(1), 620–628. https://doi.org/10.32584/jpi.v5i1.857
  5. Bastiana, Wahyu, D., Rachmayanti, N., Pertiwi, M., Biotech, M., & Surya, P. A. (2021). Sosialisasi Vaksinasi Covid-19 dan Pemeriksaan IgG Kuantitatif Pre dan Pasca Vaksinasi Kepada Mahasiswa Magang di RSI Jemursari Surabaya. Seminar Nasional Pengabdian Kepada Masyarakat 2021, 888–896.
  6. Burckhardt, R. M., Dennehy, J. J., Poon, L. L. M., Saif, L. J., & Enquist, L. W. (2022). Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters. Journal of Virology, 96(3). https://doi.org/10.1128/jvi.01973-21
  7. Carolina, M., & Agustiani, F. N. (2021). Menjawab Tantangan Pelaksanaan Vaksinasi Covid-19. Buletin APBN, VI(4), 7–10.
  8. Choudhary, H. R., Parai, D., Dash, G. C., Peter, A., Sahoo, S. K., Pattnaik, M., Rout, U. K., Nanda, R. R., Pati, S., & Bhattacharya, D. (2021). IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection. Infection, 49(5), 1045–1048. https://doi.org/10.1007/s15010-021-01651-4
  9. Dinas Kesehatan Surabaya. (2021). Pentingnya Vaksinasi Covid-19. Dinkes.Surakarta.Go.Id. https://dinkes.surakarta.go.id/pentingnya-vaksinasi-covid-19/
  10. drg. Widyawati, M. (2022). Tambah Regimen Baru Vaksin Booster, Total Ada 6 Jenis Vaksin COVID-19 yang Dipakai di Indonesia. Sehat Negeriku, 1–15. https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20220228/2439416/tambah-regimen-baru-vaksin-booster-total-ada-6-jenis-vaksin-covid-19-yang-dipakai-di-indonesia/
  11. Febriani. (2021). Titer Antibodi Covid-19 : Pengertian dan Fungsinya. ciputrahospital.com. https://ciputrahospital.com/titer-antibodi-covid-19-pengertian-dan-fungsinya/
  12. Gobbi, F., Buonfrate, D., Moro, L., Rodari, P., Piubelli, C., Caldrer, S., Riccetti, S., Sinigaglia, A., & Barzon, L. (2021). Antibody response to the bnt162b2 mrna covid-19 vaccine in subjects with prior sars-cov-2 infection. Viruses, 13(3), 21–22. https://doi.org/10.3390/v13030422
  13. Halodoc.com. (2021). Waktu yang Tepat untuk Lakukan Tes Imunologi. halodoc.com. https://www.halodoc.com/artikel/kapan-waktu-yang-tepat-untuk-lakukan-tes-imunologi
  14. Hanie, D. (2021). Cek Kekebalan Tubuh Melalui Tes Antibodi Kuantitatif SARS-CoV 2. Primaya Hospital Group, 1–7. https://primayahospital.com/press-release/cek-kekebalan-tubuh/
  15. Heise, G. (2021). Berapa Total Antibodi agar Kebal terhadap Virus Corona ? 1–6.
  16. Irsan, A., Mardhia, & Rialita, A. (2022). ARTIKEL PENELITIAN Konsistensi Respon Imun Humoral ( IgG ) SARS-CoV-2 Pasca. Majalah Kedokteran Andalas, 45(2), 118–125.
  17. Kamila, N. R. (2022). Capaian Vaksin Booster Covid-19 di Indonesia Alami Stagnasi. rdk.fidkom.uinjkt.ac.id. https://rdk.fidkom.uinjkt.ac.id/index.php/2022/07/11/capaian-vaksin-booster-covid-19-di-indonesia-alami-stagnasi/
  18. Keluarga, M. (2022). Artikel Fungsi dan Prosedur Tes Serologi Antibodi Kuantitatif COVID-. www.mitrakeluarga.com. https://www.mitrakeluarga.com/artikel/artikel-kesehatan/serologi-antibodi-kuantitatif
  19. Kemenkes RI. (2021). 4 Manfaat Vaksin Covid-19 yang Wajib Diketahui. Kementerian Kesehatan RI, 021, 5223017. http://upk.kemkes.go.id/new/4-manfaat-vaksin-covid-19-yang-wajib-diketahui
  20. Kholidiyah, D., Sutomo, & N, K. (2021). Hubungan Persepsi Masyarakat Tentang Vaksin Covid-19 Dengan Kecemasan Saat Akan Menjalani Vaksinasi Covid-19. Jurnal Keperawatan.
  21. Lestari, E., Kurniasari, A., & Fristiani, B. (2022). MUNCULNYA Ig M DAN Ig G TERHADAP KADAR NLR PADA PASIEN SUSPEK COVID 19. 1, 12–15.
  22. Luminturahardjo, W. (2021). Peranan Probiotik dalam Penanganan Infeksi. CDK, 48(5).
  23. Masnun, M. A., Sulistyowati, E., & Ronaboyd, I. (2021). PELINDUNGAN HUKUM ATAS VAKSIN COVID-19 DAN TANGGUNG JAWAB NEGARA PEMENUHAN VAKSIN DALAM MEWUJUDUKAN NEGARA KESEJAHTERAAN. DiH: Jurnal Ilmu Hukum, 17(1). https://doi.org/10.30996/dih.v17i1.4325
  24. Matula, Z., Gönczi, M., Bekő, G., Kádár, B., Ajzner, É., Uher, F., & Vályi-Nagy, I. (2022). Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy. Vaccines, 10(4), 1–12. https://doi.org/10.3390/vaccines10040539
  25. Nurhanisah, Y. (2021). Vak sin Booster dan Dosis Ketiga , Sama atau Beda ? indonesiabaik.id. https://indonesiabaik.id/infografis/vaksin-booster-dan-dosis-ketiga-sama-atau-beda
  26. Pascarella, G., Strumia, A., Piliego, C., Bruno, F., Del Buono, R., Costa, F., Scarlata, S., & Agrò, F. E. (2020). COVID-19 diagnosis and management: a comprehensive review. Journal of Internal Medicine, 288(2), 192–206. https://doi.org/10.1111/joim.13091
  27. Pusparini, P. (2020). Tes serologi dan polimerase chain reaction (PCR) untuk deteksi SARS-CoV-2/COVID-19. Jurnal Biomedika dan Kesehatan, 3(2), 46–48. https://doi.org/10.18051/jbiomedkes.2020.v3.46-48
  28. Rotty, I., Kristanto, E. G., Sekeon, S., Ekawardani, N., & Liwe, H. R. (2022). Formation of SARS-CoV-2 Specific Antibody after vaccination. e-CliniC, 10(1). https://doi.org/10.35790/ecl.v10i1.37193
  29. Salmaa. (2017). Penelitian Deskriptif. penerbitdepublish.com. https://penerbitdeepublish.com/penelitian-deskriptif/
  30. Shekhar, R., Garg, I., Pal, S., Kottewar, S., & Sheikh, A. B. (2021). COVID-19 vaccine booster: To boost or not to boost. In Infectious Disease Reports (Vol. 13, Nomor 4). https://doi.org/10.3390/idr13040084
  31. Sunur, I. C. (2021). Pemeriksaan Antibodi Setelah Vaksinasi COVID-19 Tidak Diperlukan.

Open Access Copyright (c) 2022 Jurnal Kebidanan Malahayati

Policies

Submissions

Other

Focus and Scope
Section Policies
Peer Review Process
Publication Frequency
Open Access Policy		Online Submissions
Author Guidelines
Copyright Notice
Privacy Statement
Author Fees		Journal Sponsorship
Journal History
Site Map
About this Publishing System
JKM (Jurnal Kebidanan Malahayati)